Maxim Group analyst Michael Okunewitch maintained a Hold rating on Gilead Sciences (GILD – Research Report) today. The company’s shares closed ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to ...

Gilead stock surged above a buy zone Wednesday after the company obliterated fourth-quarter forecasts and issued an upbeat ...

Operator Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2024 earnings conference call. My ...

As Finance Minister Nirmala Sitharaman will present the Budget 2025 on Saturday at 11 am, experts anticipate that the government will focus on AI-driven initiatives. They suggest that Budget 2025 ...

Today's announcement builds on a collaboration aimed at creating capacity to allow Gilead to continue its focus and mission, aimed at discovering and delivering critical medicines for cancer ...

Focus Features is nearing a deal to produce a feature adaptation of “Audition” based on the 1997 horror-thriller novel by Ryū Murakami, which was originally brought to the screen by Japanese ...

WASHINGTON (Reuters) -The International Energy Agency's former oil industry and market chief criticized the agency's focus on the global energy transition in a report released on Wednesday, and said ...